IBMS Congress 2025

Regulatory lymphoyctes in transplantation

9am – 9.30am BST, 23 September 2025 ‐ 30 mins

Immunology

Learning outcomes

HLA disease associations – ankylosing spondylitis and coeliac disease

9.30am – 10am BST, 23 September 2025 ‐ 30 mins

Immunology

Abstract

Learning outcomes

UK NEQAS and BSHI guideline: Laboratory testing and clinical interpretation of HLA genotyping results supporting the diagnosis of coeliac disease

10.30am – 11am BST, 23 September 2025 ‐ 30 mins

Immunology

Abstract

Learning outcomes

C1 esterase inhibitor (C1INH) defi ciency – innovative approaches to the management of a rare condition

11am – 11.30am BST, 23 September 2025 ‐ 30 mins

Immunology

Learning outcomes

Functional plasma kallikrein assay as a diganostic tool for bradykinin-mediated angioedema

11.30am – 12pm BST, 23 September 2025 ‐ 30 mins

Immunology

Learning Outcomes

Anti-tumour necrosis factor (TNF) drugs/ antibodies – an external quality assessment perspective

9am – 9.30am BST, 24 September 2025 ‐ 30 mins

Immunology

Learning outcomes

Autoimmunity and allergy: Our experience of reuniting immunology

9.30am – 10am BST, 24 September 2025 ‐ 30 mins

Immunology

Learning outcomes

A data-driven strategy for myositis antibodies testing

10.30am – 11am BST, 24 September 2025 ‐ 30 mins

Immunology

Learning outcomes

Validation of a new diagnostic testing pathway for systemic autoimmune rheumatic disease in primary and secondary care

11am – 11.30am BST, 24 September 2025 ‐ 30 mins

Immunology

Abstract

Speakers

Dr Adrian Heaps

Immunology – Head of Service, North Bristol NHS Trust

Find out more

Update on national project on anti-GBM testing

11.30am – 12pm BST, 24 September 2025 ‐ 30 mins

Immunology

Learning outcomes

Specialist Portfolio & HSD Q&A

12.45pm – 1.45pm BST, 24 September 2025 ‐ 1 hour

Immunology

Immunology in iLFT – our fi rst 5 years experience in NHS Tayside

2pm – 2.30pm BST, 24 September 2025 ‐ 30 mins

Immunology

Learning outcomes

Iterative improvement of monoclonal gammopathy of undetermined signifi cance (MGUS) monitoring and functionality for the EXTENT system

2.30pm – 3pm BST, 24 September 2025 ‐ 30 mins

Immunology

Abstract

Learning outcomes

New uses for flow cytometry in clinical immunology

3pm – 3.30pm BST, 24 September 2025 ‐ 30 mins

Immunology

Abstract

Learning outcomes

Speakers

Dr Aarnoud Huissoon

Consultant Immunologist, University Hospitals Birmingham NHS Foundation Trust

Find out more

Newborn screening for severe combined immunodeficiency: The role of the flow cytometry laboratory

4pm – 4.30pm BST, 24 September 2025 ‐ 30 mins

Immunology

Learning outcomes

A rare case of Artemis severe combined immunodeficiency

4.30pm – 5pm BST, 24 September 2025 ‐ 30 mins

Immunology

Abstract

Learning outcomes

Antinuclear antibodies: current practice and impact of International Consensus on Antinuclear Antibody Patterns (ICAP) nomenclature

9am – 9.30am BST, 25 September 2025 ‐ 30 mins

Immunology

Abstract

Learning outcomes

HSD management case: The evaluation of the Svar functional complement assay on the Dynex DS2

9.30am – 10am BST, 25 September 2025 ‐ 30 mins

Immunology

Learning outcomes

Intrathecal inflammation, the neuroimmunology lab’s role

10.30am – 11am BST, 25 September 2025 ‐ 30 mins

Immunology

Learning outcomes

Neurofilament light chain: An emerging biomarker for neurodegenerative disease

11am – 11.30am BST, 25 September 2025 ‐ 30 mins

Immunology

Abstract

Learning outcomes

Clinical aspects of immune-mediated ataxia

11.30am – 12pm BST, 25 September 2025 ‐ 30 mins

Immunology

Abstract

Learning outcomes

One patient’s perspective of an MS diagnosis

2pm – 2.30pm BST, 25 September 2025 ‐ 30 mins

Immunology

Life’s good, it’s the disease that’s the problem

2.30pm – 3pm BST, 25 September 2025 ‐ 30 mins

Immunology

Living with gluten ataxia – my personal journey

3pm – 3.30pm BST, 25 September 2025 ‐ 30 mins

Immunology